Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy May 11, 2024
PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases Feb 29, 2024
Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer Nov 7, 2023